ZA936133B - Fatty acid treatment - Google Patents

Fatty acid treatment

Info

Publication number
ZA936133B
ZA936133B ZA936133A ZA936133A ZA936133B ZA 936133 B ZA936133 B ZA 936133B ZA 936133 A ZA936133 A ZA 936133A ZA 936133 A ZA936133 A ZA 936133A ZA 936133 B ZA936133 B ZA 936133B
Authority
ZA
South Africa
Prior art keywords
fatty acid
acid treatment
treatment
prevention
acid
Prior art date
Application number
ZA936133A
Other languages
English (en)
Inventor
David Frederick Horrobin
Brenda Elizabeth Reynolds
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of ZA936133B publication Critical patent/ZA936133B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA936133A 1992-08-21 1993-08-20 Fatty acid treatment ZA936133B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929217781A GB9217781D0 (en) 1992-08-21 1992-08-21 Fatty acid treatment

Publications (1)

Publication Number Publication Date
ZA936133B true ZA936133B (en) 1994-03-17

Family

ID=10720717

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA936133A ZA936133B (en) 1992-08-21 1993-08-20 Fatty acid treatment

Country Status (17)

Country Link
EP (1) EP0585027B1 (xx)
JP (1) JPH06172169A (xx)
KR (1) KR940003552A (xx)
CN (1) CN1090490A (xx)
AT (1) ATE164518T1 (xx)
AU (1) AU666748B2 (xx)
CA (1) CA2104566A1 (xx)
DE (1) DE69317716T2 (xx)
DK (1) DK0585027T3 (xx)
ES (1) ES2117104T3 (xx)
GB (1) GB9217781D0 (xx)
GR (1) GR3026708T3 (xx)
MY (1) MY131357A (xx)
NO (1) NO932984L (xx)
NZ (1) NZ248451A (xx)
RU (1) RU2122408C1 (xx)
ZA (1) ZA936133B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10058521B2 (en) 2012-06-17 2018-08-28 Matinas Biopharma Inc. Omega-3 pentaenoic acid compositions and methods of use

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2119000A1 (en) * 1993-03-19 1994-09-20 David Frederick Horrobin Formulation for use in smokers
US5668174A (en) * 1993-12-29 1997-09-16 Kowa Tekuno Sachi Co., Ltd. Method of treating hyperparathyroidism
AU693312B2 (en) * 1995-01-18 1998-06-25 Taisho Pharmaceutical Co., Ltd. Remedy for dermatitis
GB9617847D0 (en) 1996-08-27 1996-10-09 Scotia Holdings Plc Fatty acid treatment
JP4607264B2 (ja) * 1998-12-01 2011-01-05 生化学工業株式会社 ヒアルロン酸を有効成分とする異所性石灰化抑制剤
AU2002318135B2 (en) * 2001-05-14 2007-08-02 Dsm Ip Assets B.V. Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
FR2839887A1 (fr) 2002-05-22 2003-11-28 Synergia Nouvelles compositions nutraceutiques et pharmaceutiques et leurs utilisations
JP4575105B2 (ja) * 2004-10-07 2010-11-04 ポリエン・プロジェクト有限会社 骨芽細胞活性抑制剤
CN103202483A (zh) * 2012-01-11 2013-07-17 浙江康恩贝健康产品有限公司 一种补钙营养组合物
MX2018014140A (es) * 2016-06-01 2019-02-25 Nestec Sa Composicion para usar en la profilaxis de enfermedades alergicas.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3474633D1 (en) * 1984-02-01 1988-11-24 Tpo Pharmachim Means for the treatment and the prophylaxis of uratic and mixed uratic lithiasis
CA1302879C (en) * 1986-05-02 1992-06-09 Vicki E. Kelley Composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine
GB9112052D0 (en) * 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10058521B2 (en) 2012-06-17 2018-08-28 Matinas Biopharma Inc. Omega-3 pentaenoic acid compositions and methods of use

Also Published As

Publication number Publication date
ATE164518T1 (de) 1998-04-15
AU4474893A (en) 1994-02-24
DE69317716D1 (de) 1998-05-07
MY131357A (en) 2007-08-30
GR3026708T3 (en) 1998-07-31
JPH06172169A (ja) 1994-06-21
CN1090490A (zh) 1994-08-10
EP0585027B1 (en) 1998-04-01
RU2122408C1 (ru) 1998-11-27
AU666748B2 (en) 1996-02-22
GB9217781D0 (en) 1992-10-07
DE69317716T2 (de) 1998-09-17
NZ248451A (en) 1997-07-27
DK0585027T3 (da) 1998-05-11
KR940003552A (ko) 1994-03-12
ES2117104T3 (es) 1998-08-01
NO932984D0 (no) 1993-08-20
CA2104566A1 (en) 1994-02-22
NO932984L (no) 1994-02-22
EP0585027A1 (en) 1994-03-02

Similar Documents

Publication Publication Date Title
MY109928A (en) Fatty acid treatment
DE3570362D1 (en) Pharmaceutical or dietetic composition having a high antithrombotic and antiarteriosclerotic activity
IL129367A0 (en) Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
NZ299464A (en) Use of gamma linolenic or dihomogamma linolenic acid in the treatment of Huntington's Chorea
JPS6422819A (en) Amnesia treating or preventing composition
ATE98125T1 (de) Zusammensetzungen essentieller fettsaeuren und therapie.
ZA936133B (en) Fatty acid treatment
GR3025178T3 (en) Medicament for the treatment of vulvar dystrophy or vaginal dryness
RU93049092A (ru) Лечение жирными кислотами
DK0598365T3 (xx)
MY129218A (en) Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid